Skip to main content
HeartCited

Quercetin pour Atherosclerosis

D Recherche Seules des recherches préliminaires existent (études en laboratoire, rapports de cas).

In vitro evidence for PCSK9 inhibition and reduced foam cell formation. Limited human data on atherosclerosis endpoints specifically.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dquercetin\u0026condition\u003Datherosclerosis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

En conclusion

In vitro evidence for PCSK9 inhibition and reduced foam cell formation. Limited human data on atherosclerosis endpoints specifically.

Key Study Findings

Other
Exploration of Potential Targets and Molecular Mechanisms of the Yiqi Jianpi Tongqiao Formula in Treating …
Dose: None vs: Allergic rhinitis mouse model vs control Outcome: Rhinitis symptoms and serum inflammatory indicators Effet: None None

Population: Allergic rhinitis mouse model

Review
Using herbal medicine to target the "microbiota-metabolism-immunity" axis as possible therapy for cardiovascular disease.
Dose: None vs: None Outcome: Gut microbiota composition Effet: None None

Population: None

In Vitro
Dietary Polyphenols in the Prevention of Stroke.
Dose: None vs: None Outcome: Stroke prevention Effet: None None

Population: General population (CVD risk)

Key Statistics

2

Études

100

Participants

Positive

D

Note

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
500-1,000 mg/day
bloodpressuresupport:
500-730 mg/day

Limite supérieure : Not formally established; up to 1,000 mg/day used in clinical trials

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

Moment optimal de prise : With meals; vitamin C co-supplementation may enhance bioavailability

Safety & Side Effects

Effets indésirables signalés

  • Generally well-tolerated
  • Headache (rare)
  • Mild gastrointestinal discomfort
  • Tingling in extremities (rare, high doses)

Interactions connues

  • Antibiotics (quinolones — may reduce efficacy)
  • Cyclosporine (may increase blood levels)
  • Anticoagulants (may have mild antiplatelet effect)
  • Blood pressure medications (additive effect)

Apport maximal tolérable : Not formally established; up to 1,000 mg/day used in clinical trials

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Quercetin help with Atherosclerosis?
Based on 2 studies with 100 participants, there is preliminary evidence that needs more research that Quercetin may support Atherosclerosis management. Our evidence grade is D (Very Early Research).
How much Quercetin should I take for Atherosclerosis?
Studies have used various dosages. A commonly studied range is 500-1,000 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Quercetin?
Reported side effects may include Generally well-tolerated, Headache (rare), Mild gastrointestinal discomfort, Tingling in extremities (rare, high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Quercetin and Atherosclerosis?
We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

References

  1. [1] Sihong Huang et al.. Curr Comput Aided Drug Des. 2025. Exploration of Potential Targets and Molecular Mechanisms of the Yiqi Jianpi Tongqiao Formula in Treating Allergic Rhinitis Mouse Model based … doi:10.2174/0115734099299714240516160158 PubMed
  2. [2] Masoumeh Shamsi et al.. Iran J Pharm Res. 2024. Dual Modulation of Canonical and Non-canonical TGF-β/ROS/Erk1/2 Pathways: Synergistic Activation of Nrf-2 and Antioxidant Enzymes (SOD1, GPx, HO-1) by Quercetin … doi:10.5812/ijpr-151428 PubMed
  3. [3] Wang Anlu et al.. Pharmacol Res. 2019. Using herbal medicine to target the "microbiota-metabolism-immunity" axis as possible therapy for cardiovascular disease. doi:10.1016/j.phrs.2019.02.018 PubMed
  4. [4] A Tressera-Rimbau et al.. Oxid Med Cell Longev. 2017. Dietary Polyphenols in the Prevention of Stroke. doi:10.1155/2017/7467962 PubMed

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.